BioNTech AG Enters into Licensing Agreement with

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
118
BioNTech AG Enters into Licensing Agreement with CELLSCRIPT, LLC as it Advances Development of Messenger RNA Encoding Bispecific Antibodies and other Therapeutic Proteins

MAINZ, Germany, Sept. 06, 2017 (GLOBE NEWSWIRE) -- BioNTech AG, a fully integrated biotechnology company pioneering individualized cancer immunotherapy, today announced that it has entered into a broad and comprehensive non-exclusive patent licensing agreement with CELLSCRIPT, LLC covering nucleoside-modified messenger RNA (mRNA) for use in all in vivo applications, including therapeutic and non-therapeutic applications in humans and animals. Modified mRNAs covered by these technologies exhibit reduced innate immunogenicity, thereby allowing repeated dosing of mRNA therapeutics for the treatment of cancer and other diseases such as protein-deficient rare diseases. The modified mRNA technology is complementary to, but separate from, BioNTech's other mRNA technologies used in its clinical-stage cancer vaccines for the treatment of cancer. Financial details of the agreement were not disclosed.

The patents for CELLSCRIPT’s nucleoside-modified RNA technologies are the result of research conducted by Prof. Katalin Karikó, Ph.D. and Drew Weissman, M.D., Ph.D. at the University of Pennsylvania Medical School. Prof. Karikó, one of the world’s leading experts in mRNA biochemistry, with more than 30 years of experience, joined BioNTech in 2013. She has published more than 70 peer-reviewed papers and conducted groundbreaking research into the discovery that incorporation of modified nucleosides suppresses immunogenicity of RNA, consequently demonstrating the feasibility of using nucleoside-modified mRNA for protein replacement in vivo . She is co-inventor of therapeutic mRNA-related patents, including the patents for RNA containing modified nucleosides.

BioNTech recently reported preclinical animal data in Nature Medicine demonstrating that in vivo delivery of mRNA encoding T cell-engaging bispecific antibodies eliminated aggressive large tumors in mice.  Administering an mRNA encoding a bispecific antibody and thereby enabling the patient’s body to act as a factory, synthesizing the active therapeutic antibody itself, may profoundly reduce complexity and decrease drug development times compared to protein-based approaches.

“Our recently published data on bispecific antibodies reinforces the significant potential of this new therapeutic approach,” said Prof. Ugur Sahin, founder and CEO of BioNTech. “CELLSCRIPT’s technology will play an important role in our efforts to develop first-in-class mRNA-encoded antibodies and other therapies for the treatment of cancer and other diseases.”

BioNTech’s modified mRNA program complements the company’s larger portfolio of clinical-stage individualized RNA cancer vaccines. While modified mRNA is designed to be immunologically silent, BioNTech’s mRNA cancer vaccine treatments are optimized for appropriate immune stimulation and translation in immune cells.   

About BioNTech AG

BioNTech is Europe’s largest privately held biopharmaceutical company pioneering the development of individualized therapies for treatment of cancer and other diseases. The company combines all building blocks for individualized immunotherapy under one roof – from diagnostics and drug development to manufacturing. Its cutting-edge technologies range from individualized mRNA-based medicines through innovative chimeric antigen receptors and T-cell receptor-based products to novel bispecific antibody-based immunomodulators. BioNTech’s approach is validated by five top-tier corporate partnerships with Genentech, Genmab, Eli Lilly and Company, Sanofi and Bayer Animal Health. Founded in 2008, BioNTech’s financial shareholders include the MIG Fonds, Salvia and the Strüngmann Family Office, with the Strüngmann Family Office as the majority shareholder.

More information about BioNTech is available at www.biontech.de . 

About CELLSCRIPT, LLC

CELLSCRIPT, based in Madison, Wisconsin, USA, is focused on development and uses of RNA for translation in cells for clinical research and therapeutics. 

More information about CELLSCRIPT is available at www.cellscript.com .

For more information, please contact: General Inquiries: BioNTech AG Regina Jehle Tel: +49 6131 9084 1273 Email: Regina.Jehle@biontech.de US Media & Investors: ICR Healthcare James Heins / Stephanie Carrington Tel: +1 203 682 8251 Tel: +1 646 277 1282 Email: James.Heins@icrinc.com Email: Stephanie.Carrington@icrinc.com International Media & Investor Inquiries: akampion Dr. Ludger Wess / Ines-Regina Buth Tel: +49 40 8816 5964 Tel: +49 30 2363 2768 Email: info@akampion.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Golf Cart Market Set to Surge as Electric Mobility Rises

Updated Category News Views 128

Revving Up the Golf Cart Market The golf cart market's looking like it's gearing up for one heck of a drive. Mordor Intelligence just dropped a report claiming we're gonna see the market haul itself from USD 2.44 billion in 2026 to USD 3.24 billion by 2031. That’s a tidy little jump with a CAGR of 5.81%. Blame it on electric mobility's allure, spruced-up lithium battery...

Continue Reading
WIC 2026: Global Connectivity and Cyber Futures

Updated Category News Views 117

Connectivity Takes Center Stage in Wuzhen When you throw 1,800 movers and shakers into a room focused on the future of the internet, sparks are gonna fly. That's exactly what's going down at the 2026 World Internet Conference in Wuzhen, China. Brass tacks: this ain't just another snooze-fest. The theme this year screams significance—'Open Source and Openness, Joined...

Continue Reading
Bowling Makes a Strike at Macy's 100th Parade in NYC

Updated Category News Views 64

Rolling with Tradition: Bowling at Macy's Parade Back in the day, bowling wasn't exactly the sport making headlines. But times, they change. Here we are in the thick of things, witnessing Go Bowling getting its moment in the spotlight during the historic 100th Macy's Thanksgiving Day Parade®. It's not about raking in the dough or hitting some stocks; it’s about...

Continue Reading
Dr. Lachlan Forrow Honored with ASF Lifetime Achievement Award

Updated Category News Views 50

Championing a Legacy of Compassion in Medicine Listen up: not every day you hear about someone leading healthcare with a soul. Here's Dr. Lachlan Forrow, celebrated by the Albert Schweitzer Fellowship for shaping bioethics and medical humanism for over forty years. This fella's carved out a niche that melds heart with healthcare, and that's why he's scoring the inaugural...

Continue Reading
SAGA Metals Enters Decision-Making Circles in Canada

Updated Category News Views 63

Stepping into the Big Leagues Seems like SAGA Metals is making a gutsy move, stepping into some heavy-hitting circles. They just hitched their wagon to the Canadian Chamber of Commerce's Critical Minerals Council. That's not just a foot in the door; that's walking right into the room where national policy gets cooked up. Joining forces here could be their ticket to...

Continue Reading
Beetles Gel Polish Debuts Bold Halloween Nail Kit

Updated Category News Views 138

Diving Deep into Beetles Gel Polish's Gothic Launch In a world where nail polish can ignite passions and trends, Beetles Gel Polish is pulling out all the stops with its latest Halloween venture. This ain't your average nail kit, folks. We're talking about the Vampiric Feast Gift Box—an 8-color powerhouse designed to transform your nails into bloody, gothic...

Continue Reading
Digging Deep: How Excavation Preps Before the First Shovel

Updated Category News Views 68

Laying the Groundwork Before Breaking Any Ground When it comes to excavation, it's not just about firing up the heavy machinery and hoping for the best. There's a whole lot of groundwork—pun definitely intended—that goes into prepping a site before any actual digging begins. Kenneth Zittel, an Excavation Expert, gives us the lowdown on how it’s done, and let me tell...

Continue Reading
EPG's New Malaysian Factory: A US$120M Commitment

Updated Category News Views 97

In the hustle and bustle of manufacturing, EPG Modular Data Center has hit a landmark moment. They're not just slapping up another building—they're carving out a piece of future tech infrastructure with their fresh Malaysia FIZ Factory. Investing in Regional Strength When you pump US$120 million into a project, you're doing more than sinking cash into concrete—you're...

Continue Reading
Ez1099 2026: Simplifying Tax Filing Game Plan

Updated Category News Views 45

Simplifying Tax Filing: Say Goodbye to TCCs The gripes of chasing after IRS Transmitter Control Codes are about to be as outdated as rotary phones. Halfpricesoft has just rolled out its ez1099 2026 tax software, and folks, it's ready to change the game for the 2027 tax season. Forget the traditional IRS Fire system, as it's about to be retired soon—I mean, who wants to...

Continue Reading
Provider Services M&A Spark Interest Amid Market Changes

Updated Category News Views 66

A Gritty Look at the Provider Services Market Well, here's the deal: provider services mergers and acquisitions (M&A) are stirring back to life after dragging their feet through 2025. It's not a full-blown sprint yet, but we've got subtle signals of a market warming up to the idea of change and growth. Brown Gibbons Lang & Company (BGL) has the lowdown in their freshly...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Arch Capital Group's Stock Performance Analysis

Updated Category News Views 162

Understanding Stock Performance at Arch Capital Group Arch Capital Group Inc. (NASDAQ: ACGL) is currently priced at $88.38, reflecting a 0.32% dip in its trading value. Over the past month, this stock has experienced a decline of 1.97%, and examining its trajectory over the last year reveals an overall decrease of 8.47%. These numbers may lead long-term investors to...

Continue Reading
Greenland Resources Secures $10 Million Financing for Growth

Updated Category News Views 124

Greenland Resources Secures $10 Million Financing for Growth Greenland Resources Inc. (“Greenland Resources” or the “Company”; Neo: MOLY, Frankfurt: M0LY) has recently announced an exciting opportunity for investors - a non-brokered private placement aimed at raising C$10 million through the issuance of units at a price of C$1.50 each. This strategic move is set...

Continue Reading
KOIL Energy Secures Major Contract for Subsea Equipment Supply

Updated Category News Views 170

KOIL Energy's Groundbreaking Contract Achievement KOIL Energy Solutions, Inc. (OTCQB: KLNG) has recently achieved a significant milestone by securing a contract to supply six Steel Tube Flying Leads and related equipment for a large-scale project in the Gulf of America. This vital equipment will enhance the control of subsea fields operated by an esteemed international...

Continue Reading
Projected Rise of Smart Grid Market to $207.82 Billion

Updated Category News Views 84

Overview of the Smart Grid Market Growth The Smart Grid market is on an impressive trajectory, with projections indicating a value of USD 207.82 billion by 2031. This remarkable growth, reflected in a compound annual growth rate (CAGR) of 19.9% during the forecast period, stems from continuous technological advancements that meet the growing demand for electricity and...

Continue Reading
Futu Holdings Lawsuit: Investors Eye Key Deadline

Updated Category News Views 19

Investor Turbulence: Futu’s Legal Storm Unfolds If you’ve been keeping an eye on Futu Holdings (NASDAQ: FUTU), you might want to adjust your chair for this one. The company’s entangled in a rough-and-tumble securities fraud class action lawsuit, dragging its stock price down and mucking up investor sentiment. It’s a bruising scene for everyone who snagged shares...

Continue Reading